Changeflow GovPing Healthcare & Life Sciences FDA CDRH Approves Variance for Trio Charlotte
Routine Rule Added Final

FDA CDRH Approves Variance for Trio Charlotte

Email

Summary

FDA's Center for Devices and Radiological Health (CDRH) has approved a variance for Trio Charlotte, granting regulatory relief from specific medical device requirements under FDA jurisdiction. The variance approval letter was issued under docket FDA-2026-V-2880-0003. This individual variance applies specifically to Trio Charlotte and does not establish broader precedent for other medical device manufacturers seeking similar relief.

Published by FDA on regulations.gov . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors Regs.gov: Food and Drug Administration for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 379 changes logged to date.

What changed

FDA CDRH issued an approval letter granting Trio Charlotte a variance from certain medical device regulatory requirements. The variance provides specific regulatory relief tailored to Trio Charlotte's circumstances and device operations. Affected parties seeking similar variance relief should submit individual requests to FDA CDRH with supporting justification, as each variance is evaluated on its own merits and does not create binding precedent for other manufacturers.

Archived snapshot

Apr 23, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

Content

There are no documents available to view or download

Attachments 1

Variance Approval Letter from FDA CDRH to Trio Charlotte

More Information
- Author(s) CDRH
Download

Get daily alerts for Regs.gov: Food and Drug Administration

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from FDA.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
FDA
Instrument
Rule
Branch
Executive
Legal weight
Binding
Stage
Final
Change scope
Minor
Docket
FDA-2026-V-2880-0003

Who this affects

Applies to
Medical device makers
Industry sector
3345 Medical Device Manufacturing
Activity scope
Variance approval Regulatory compliance
Geographic scope
United States US

Taxonomy

Primary area
Medical Devices
Operational domain
Regulatory Affairs
Topics
Healthcare

Get alerts for this source

We'll email you when Regs.gov: Food and Drug Administration publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!